Advancements in Heavy Metal Detection Using Microneedle Array Technology.

Abstract

Heavy metal and metalloid (HM) exposure poses significant health risks, including cardiovascular disease, cancer, and renal damage. This contamination, prevalent in the Western U.S., involves Arsenic (As), Cadmium (Cd), Uranium (U), and Vanadium (V). Interstitial fluid (ISF) is a source of biomarkers, which can be minimally invasively collected using microneedle array (MA) technology. Our study hypothesized that MA-extracted ISF would facilitate non-invasive HM quantification. We established analytical parameters for HM detection in ISF using inductively coupled plasma-mass spectrometry (ICP-MS), defined baseline ISF HM concentrations in unexposed animal populations, and monitored HM levels in ISF under mixed exposure in animal models. Additionally, we assessed HM levels in ISF and biological fluids from three human subjects. Thirty-six Sprague Dawley rats were divided into cohorts: low-level mixed HMs exposure (5X maximum contaminant level (MCL)); high-level single HM with low-level others (50X MCL for one HM with 5X for others); and unexposed controls. ISF and plasma were collected weekly for eight weeks and analyzed via ICP-MS. Our findings reveal a correlation between ISF and plasma HM levels, underscoring ISF's potential for real-time monitoring of HM exposure. This study also establishes baseline ISF HM levels, illustrating the feasibility of HM quantification using small ISF volumes.